Do Hemodynamic Definitions of Chronic Thromboembolic Pulmonary Hypertension Distinguish Between Distinct Phenotypes of Chronic Thromboembolic Pulmonary Disease?

Autor: Cerrone E; Sheffield Teaching Hospitals NHS Foundation Trust, Pulmonary Vascular Disease Unit, Sheffield, United Kingdom of Great Britain and Northern Ireland., Hameed AG; Sheffield Teaching Hospitals NHS Foundation Trust, Pulmonary Vascular Disease Unit, Sheffield, United Kingdom of Great Britain and Northern Ireland.; The University of Sheffield Department of Infection Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom of Great Britain and Northern Ireland., Kiely DG; Sheffield Teaching Hospitals NHS Foundation Trust, Pulmonary Vascular Disease Unit, Sheffield, United Kingdom of Great Britain and Northern Ireland.; The University of Sheffield Department of Infection Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom of Great Britain and Northern Ireland.; NIHR Sheffield Biomedical Research Centre , Sheffield, United Kingdom of Great Britain and Northern Ireland., Condliffe R; Sheffield Teaching Hospitals NHS Foundation Trust, Pulmonary Vascular Disease Unit, Sheffield, United Kingdom of Great Britain and Northern Ireland.; The University of Sheffield Department of Infection Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom of Great Britain and Northern Ireland., Swift AJ; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom of Great Britain and Northern Ireland.; The University of Sheffield Department of Infection Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom of Great Britain and Northern Ireland.; The University of Sheffield Insigneo Institute for in silico Medicine, Sheffield, South Yorkshire, United Kingdom of Great Britain and Northern Ireland., Rajaram S; Sheffield Teaching Hospitals NHS Foundation Trust, Department of Radiology, Sheffield, United Kingdom of Great Britain and Northern Ireland., Smith I; Sheffield Teaching Hospitals NHS Foundation Trust, Pulmonary Vascular Disease Unit, Sheffield, United Kingdom of Great Britain and Northern Ireland.; The University of Sheffield Department of Infection Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom of Great Britain and Northern Ireland., Hurdman JA; Sheffield Teaching Hospitals NHS Foundation Trust, Pulmonary Vascular Disease Unit, Sheffield, United Kingdom of Great Britain and Northern Ireland.; The University of Sheffield Department of Infection Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom of Great Britain and Northern Ireland., Elliot CA; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom of Great Britain and Northern Ireland.; The University of Sheffield Department of Infection Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom of Great Britain and Northern Ireland., Thompson AAR; The University of Sheffield, Department of Infection, Immunity and Cardiovascular Disease, Sheffield, United Kingdom of Great Britain and Northern Ireland.; Sheffield Teaching Hospitals NHS Foundation Trust, Pulmonary Vascular Disease Unit, Sheffield, United Kingdom of Great Britain and Northern Ireland., Rothman AM; The University of Sheffield, Department of Infection, Immunity and Cardiovascular Disease, Sheffield, United Kingdom of Great Britain and Northern Ireland.; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom of Great Britain and Northern Ireland.; The University of Sheffield, INSIGNEO, Institute for In Silico Medicine, Sheffield, United Kingdom of Great Britain and Northern Ireland., Charalampopoulos A; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom of Great Britain and Northern Ireland.; The University of Sheffield Department of Infection Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom of Great Britain and Northern Ireland; athanasios.charalampopoulos@nhs.net.

Publikováno v: Annals of the American Thoracic Society [Ann Am Thorac Soc] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.

Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry.

Autor: Durrington C; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Division of Clinical Medicine, University of Sheffield, Sheffield, UK., Hurdman JA; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Elliot CA; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Maclean R; Department of Haematology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Van Veen J; Department of Haematology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Saccullo G; Department of Haematology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., De-Foneska D; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Swift AJ; Division of Clinical Medicine, University of Sheffield, Sheffield, UK.; Department of Radiology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Insigneo Institute, University of Sheffield, Sheffield, UK.; National Institute for Health and Care Research Sheffield Biomedical Research Centre, Sheffield, UK., Smitha R; Division of Clinical Medicine, University of Sheffield, Sheffield, UK.; Department of Radiology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Hill C; Department of Radiology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Thomas S; Department of Radiology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Dwivedi K; Division of Clinical Medicine, University of Sheffield, Sheffield, UK.; Department of Radiology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Alabed S; Division of Clinical Medicine, University of Sheffield, Sheffield, UK.; Department of Radiology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Wild JM; Department of Radiology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Insigneo Institute, University of Sheffield, Sheffield, UK.; National Institute for Health and Care Research Sheffield Biomedical Research Centre, Sheffield, UK., Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Hameed A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Division of Clinical Medicine, University of Sheffield, Sheffield, UK., Rothman AMK; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Division of Clinical Medicine, University of Sheffield, Sheffield, UK.; National Institute for Health and Care Research Sheffield Biomedical Research Centre, Sheffield, UK., Watson L; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Hamilton N; Division of Clinical Medicine, University of Sheffield, Sheffield, UK., Thompson AAR; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Division of Clinical Medicine, University of Sheffield, Sheffield, UK.; National Institute for Health and Care Research Sheffield Biomedical Research Centre, Sheffield, UK., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Division of Clinical Medicine, University of Sheffield, Sheffield, UK.; National Institute for Health and Care Research Sheffield Biomedical Research Centre, Sheffield, UK.; R. Condliffe and D.G. Kiely contributed equally to this work., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK David.kiely1@nhs.net.; Division of Clinical Medicine, University of Sheffield, Sheffield, UK.; Insigneo Institute, University of Sheffield, Sheffield, UK.; National Institute for Health and Care Research Sheffield Biomedical Research Centre, Sheffield, UK.; R. Condliffe and D.G. Kiely contributed equally to this work.

Publikováno v: The European respiratory journal [Eur Respir J] 2024 Mar 14; Vol. 63 (3). Date of Electronic Publication: 2024 Mar 14 (Print Publication: 2024).

Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension.

Autor: Alabed S; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK s.alabed@nhs.net.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK.; INSIGNEO, Institute for in silico Medicine, University of Sheffield, Sheffield, UK., Garg P; Norwich Medical School, University of East Anglia, Norwich, UK., Alandejani F; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Dwivedi K; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK., Maiter A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK., Karunasaagarar K; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK., Rajaram S; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK., Hill C; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK., Thomas S; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK., Gossling R; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Sharkey MJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Salehi M; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Wild JM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; INSIGNEO, Institute for in silico Medicine, University of Sheffield, Sheffield, UK., Watson L; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Hameed A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Lu H; INSIGNEO, Institute for in silico Medicine, University of Sheffield, Sheffield, UK.; Department of Computer Science, University of Sheffield, Sheffield, UK., Rothman AMK; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Thompson AAR; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Elliot CA; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Hamilton N; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Johns CS; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK., Armstrong I; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Condliffe R; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., van der Geest RJ; Leiden University Medical Center, Leiden, The Netherlands., Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK.; INSIGNEO, Institute for in silico Medicine, University of Sheffield, Sheffield, UK.; National Institute for Health and Care Research, Sheffield Biomedical Research Centre, Sheffield, UK.; Joint senior authors., Kiely DG; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.; INSIGNEO, Institute for in silico Medicine, University of Sheffield, Sheffield, UK.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.; National Institute for Health and Care Research, Sheffield Biomedical Research Centre, Sheffield, UK.; Joint senior authors.

Publikováno v: The European respiratory journal [Eur Respir J] 2023 Aug 03; Vol. 62 (2). Date of Electronic Publication: 2023 Aug 03 (Print Publication: 2023).

Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis.

Autor: Hoeper MM; Clinic of Respiratory Medicine, Hannover Medical School, member of the German Center of Lung Research (DZL), Germany. Electronic address: hoeper.marius@mh-hannover.de., Dwivedi K; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital and Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Pausch C; GWT-TUD, Epidemiological Centre, Technical University Dresden, Dresden, Germany., Lewis RA; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital and Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Olsson KM; Clinic of Respiratory Medicine, Hannover Medical School, member of the German Center of Lung Research (DZL), Germany., Huscher D; Institute of Biometry and Clinical Epidemiology, and Berlin Insitute of Health, Charité-Universitätsmedizin, Berlin, Germany., Pittrow D; GWT-TUD, Epidemiological Centre, Technical University Dresden, Dresden, Germany; Institute for Clinical Pharmacology, Medical Faculty, Technical University Dresden, Dresden, Germany., Grünig E; Center for Pulmonary Hypertension, Thoraxklinik at Heidelberg University Hospital, Translational Lung Research Center Heidelberg, member of the German Center for Lung Research (DZL), Germany., Staehler G; Lungenklinik Löwenstein, Löwenstein, Germany., Vizza CD; Dipartimento di Scienze Cliniche Internistiche, Anestiologiche e Cardiolohiche, Sapienza, University of Rome, Rome, Italy., Gall H; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center, Giessen, Germany., Distler O; Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Opitz C; Department of Cardiology, DRK Kliniken Berlin Westend, Berlin, Germany., Gibbs JSR; Department of Cardiology, National Heart & Lung Institute, Imperial College London, London, UK., Delcroix M; Clinical Department of Respiratory Diseases, University Hospitals of Leuven and Laboratory of Respiratory Diseases and Thoracic Surgery, Department of Chronic Diseases and Metabolism, Katholieke Universiteit Leuven University of Leuven, Leuven, Belgium., Park DH; Clinic of Respiratory Medicine, Hannover Medical School, member of the German Center of Lung Research (DZL), Germany., Ghofrani HA; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center, Giessen, Germany; Department of Medicine, Imperial College London, London, UK., Ewert R; Clinic of Internal Medicine, Department of Respiratory Medicine, Universitätsmedizin Greifswald, Greifswald, Germany., Kaemmerer H; Deutsches Herzzentrum München, Klinik für angeborene Herzfehler und Kinderkardiologie; TU München, Munich, Germany., Kabitz HJ; Gemeinnützige Krankenhausbetriebsgesellschaft Konstanz, Medizinische Klinik II, Konstanz, Germany., Skowasch D; Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik II, Innere Medizin - Kardiologie/Pneumologie, Bonn, Germany., Behr J; Department of Medicine V, University Hospital, LMU Munich, Comprehensive Pneumology Center Munich, member of the German Center for Lung Research (DZL), Germany., Milger K; Department of Medicine V, University Hospital, LMU Munich, Comprehensive Pneumology Center Munich, member of the German Center for Lung Research (DZL), Germany., Lange TJ; University Medical Center Regensburg, Department of Internal Medicine II, Regensburg, Germany., Wilkens H; Klinik für Innere Medizin V, Pneumologie, Universitätsklinikum des Saarlandes, Homburg, Germany., Seyfarth HJ; Universitätsklinikum Leipzig, Medizinische Klinik und Poliklinik II, Abteilung für Pneumologie, Leipzig, Germany., Held M; Department of Internal Medicine, Respiratory Medicine and Ventilatory Support, Medical Mission Hospital, Central Clinic Würzburg, Germany., Dumitrescu D; Clinic for General and Interventional Cardiology and Angiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany., Tsangaris I; Attikon University Hospital, 2nd Critical Care Department, National and Kapodistrian University of Athens, Athens, Greece., Vonk-Noordegraaf A; Amsterdam UMC, Vrije Universiteit Amsterdam, dept of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands., Ulrich S; Clinic of Pulmonology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Klose H; Department of Respiratory Medicine, Eppendorf University Hospital, Hamburg, Germany., Claussen M; LungenClinic Grosshansdorf, Fachabteilung Pneumologie, Großhansdorf, Germany., Eisenmann S; Universitätsklinikum Halle, Klinik für Innere Medizin I, Department of Respiratory Medicine, Halle, Germany., Schmidt KH; Department of Cardiology and Center of Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany., Swift AJ; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital and Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Thompson AAR; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital and Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Elliot CA; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital and Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Rosenkranz S; Clinic III for Internal Medicine (Cardiology) and Center for Molecular Medicine, and the Cologne Cardiovascular Research Center, University of Cologne, Germany., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital and Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital and Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Halank M; Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden, Medizinische Klinik und Poliklinik I, Dresden, Germany.

Publikováno v: The Lancet. Respiratory medicine [Lancet Respir Med] 2022 Oct; Vol. 10 (10), pp. 937-948. Date of Electronic Publication: 2022 Jun 28.

CMR Measures of Left Atrial Volume Index and Right Ventricular Function Have Prognostic Value in Chronic Thromboembolic Pulmonary Hypertension.

Autor: Shahin Y; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Department of Clinical Radiology, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Alabed S; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Department of Clinical Radiology, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Rehan Quadery S; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Lewis RA; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Johns C; Department of Clinical Radiology, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Alkhanfar D; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Sukhanenko M; Department of Clinical Radiology, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Alandejani F; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Garg P; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Elliot CA; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Hameed A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Wild JM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; INSIGNEO, Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Department of Clinical Radiology, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom.; INSIGNEO, Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom., Kiely DG; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom.; INSIGNEO, Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2022 Mar 14; Vol. 9, pp. 840196. Date of Electronic Publication: 2022 Mar 14 (Print Publication: 2022).